Trial intelligence / Profile preview

Aloe vera capsule vs omeprazole for 4-week treatment of symptomatic gastroesophageal reflux disease

TCTR20211102002Phase 3Recruiting

Sponsor
Dhurakij Pundit University
Start
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of aloe vera, omeprazole in gastroesophageal reflux disease (GERD), sponsored by Dhurakij Pundit University. Started Sep 2021; status: recruiting.

02

Drugs

aloe veraomeprazole
03

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on TCTR20211102002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20211102002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call